vs
Apellis Pharmaceuticals, Inc.(APLS)与TaskUs, Inc.(TASK)财务数据对比。点击上方公司名可切换其他公司
TaskUs, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍($313.0M vs $199.9M),TaskUs, Inc.净利率更高(9.5% vs -29.5%,领先39.0%),TaskUs, Inc.同比增速更快(14.1% vs -5.9%),TaskUs, Inc.自由现金流更多($9.9M vs $-14.3M),过去两年TaskUs, Inc.的营收复合增速更高(17.3% vs 7.7%)
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
CTG(Computer Task Group)是一家总部位于美国纽约布法罗的跨国信息技术人力资源服务企业,为客户提供IT领域的人才配置相关服务。2023年12月,官方宣布Cegeka完成收购该公司74%的多数股权。
APLS vs TASK — 直观对比
营收规模更大
TASK
是对方的1.6倍
$199.9M
营收增速更快
TASK
高出20.1%
-5.9%
净利率更高
TASK
高出39.0%
-29.5%
自由现金流更多
TASK
多$24.2M
$-14.3M
两年增速更快
TASK
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $199.9M | $313.0M |
| 净利润 | $-59.0M | $29.7M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 12.2% |
| 净利率 | -29.5% | 9.5% |
| 营收同比 | -5.9% | 14.1% |
| 净利润同比 | -62.2% | 235.3% |
| 每股收益(稀释后) | $-0.40 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APLS
TASK
| Q4 25 | $199.9M | $313.0M | ||
| Q3 25 | $458.6M | $298.7M | ||
| Q2 25 | $178.5M | $294.1M | ||
| Q1 25 | $166.8M | $277.8M | ||
| Q4 24 | $212.5M | $274.2M | ||
| Q3 24 | $196.8M | $255.3M | ||
| Q2 24 | $199.7M | $237.9M | ||
| Q1 24 | $172.3M | $227.5M |
净利润
APLS
TASK
| Q4 25 | $-59.0M | $29.7M | ||
| Q3 25 | $215.7M | $31.4M | ||
| Q2 25 | $-42.2M | $20.0M | ||
| Q1 25 | $-92.2M | $21.1M | ||
| Q4 24 | $-36.4M | $8.9M | ||
| Q3 24 | $-57.4M | $12.7M | ||
| Q2 24 | $-37.7M | $12.6M | ||
| Q1 24 | $-66.4M | $11.7M |
营业利润率
APLS
TASK
| Q4 25 | -25.6% | 12.2% | ||
| Q3 25 | 48.7% | 12.7% | ||
| Q2 25 | -18.6% | 10.3% | ||
| Q1 25 | -50.0% | 12.3% | ||
| Q4 24 | -12.3% | 8.0% | ||
| Q3 24 | -24.0% | 9.5% | ||
| Q2 24 | -14.7% | 9.5% | ||
| Q1 24 | -36.0% | 10.4% |
净利率
APLS
TASK
| Q4 25 | -29.5% | 9.5% | ||
| Q3 25 | 47.0% | 10.5% | ||
| Q2 25 | -23.6% | 6.8% | ||
| Q1 25 | -55.3% | 7.6% | ||
| Q4 24 | -17.1% | 3.2% | ||
| Q3 24 | -29.2% | 5.0% | ||
| Q2 24 | -18.9% | 5.3% | ||
| Q1 24 | -38.5% | 5.1% |
每股收益(稀释后)
APLS
TASK
| Q4 25 | $-0.40 | $0.31 | ||
| Q3 25 | $1.67 | $0.34 | ||
| Q2 25 | $-0.33 | $0.22 | ||
| Q1 25 | $-0.74 | $0.23 | ||
| Q4 24 | $-0.30 | $0.09 | ||
| Q3 24 | $-0.46 | $0.14 | ||
| Q2 24 | $-0.30 | $0.14 | ||
| Q1 24 | $-0.54 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $211.7M |
| 总债务越低越好 | — | $241.4M |
| 股东权益账面价值 | $370.1M | $600.0M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势,按日历期对齐
现金及短期投资
APLS
TASK
| Q4 25 | $466.2M | $211.7M | ||
| Q3 25 | $479.2M | $210.0M | ||
| Q2 25 | $370.0M | $181.9M | ||
| Q1 25 | $358.4M | $196.9M | ||
| Q4 24 | $411.3M | $192.2M | ||
| Q3 24 | $396.9M | $180.4M | ||
| Q2 24 | $360.1M | $171.1M | ||
| Q1 24 | $325.9M | $165.3M |
总债务
APLS
TASK
| Q4 25 | — | $241.4M | ||
| Q3 25 | — | $246.3M | ||
| Q2 25 | — | $249.6M | ||
| Q1 25 | — | $252.9M | ||
| Q4 24 | — | $256.2M | ||
| Q3 24 | — | $259.4M | ||
| Q2 24 | — | $261.0M | ||
| Q1 24 | $93.1M | $262.6M |
股东权益
APLS
TASK
| Q4 25 | $370.1M | $600.0M | ||
| Q3 25 | $401.2M | $567.5M | ||
| Q2 25 | $156.3M | $544.5M | ||
| Q1 25 | $164.2M | $520.3M | ||
| Q4 24 | $228.5M | $496.9M | ||
| Q3 24 | $237.1M | $489.8M | ||
| Q2 24 | $264.3M | $460.2M | ||
| Q1 24 | $266.7M | $454.6M |
总资产
APLS
TASK
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $821.4M | $1.0B | ||
| Q1 25 | $807.3M | $985.5M | ||
| Q4 24 | $885.1M | $953.3M | ||
| Q3 24 | $901.9M | $942.1M | ||
| Q2 24 | $904.5M | $886.1M | ||
| Q1 24 | $831.9M | $874.5M |
负债/权益比
APLS
TASK
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | 0.35× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $29.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $9.9M |
| 自由现金流率自由现金流/营收 | -7.1% | 3.2% |
| 资本支出强度资本支出/营收 | 0.1% | 6.3% |
| 现金转化率经营现金流/净利润 | — | 1.00× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $73.7M |
8季度趋势,按日历期对齐
经营现金流
APLS
TASK
| Q4 25 | $-14.2M | $29.7M | ||
| Q3 25 | $108.5M | $54.3M | ||
| Q2 25 | $4.4M | $17.0M | ||
| Q1 25 | $-53.4M | $36.3M | ||
| Q4 24 | $19.4M | $40.7M | ||
| Q3 24 | $34.1M | $17.0M | ||
| Q2 24 | $-8.3M | $30.0M | ||
| Q1 24 | $-133.0M | $51.2M |
自由现金流
APLS
TASK
| Q4 25 | $-14.3M | $9.9M | ||
| Q3 25 | $108.3M | $42.0M | ||
| Q2 25 | $4.4M | $38.0K | ||
| Q1 25 | $-53.4M | $21.8M | ||
| Q4 24 | $19.3M | $20.4M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | $-8.4M | $25.5M | ||
| Q1 24 | $-133.3M | $47.6M |
自由现金流率
APLS
TASK
| Q4 25 | -7.1% | 3.2% | ||
| Q3 25 | 23.6% | 14.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | -32.0% | 7.8% | ||
| Q4 24 | 9.1% | 7.4% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | -4.2% | 10.7% | ||
| Q1 24 | -77.3% | 20.9% |
资本支出强度
APLS
TASK
| Q4 25 | 0.1% | 6.3% | ||
| Q3 25 | 0.0% | 4.1% | ||
| Q2 25 | 0.0% | 5.8% | ||
| Q1 25 | 0.0% | 5.2% | ||
| Q4 24 | 0.0% | 7.4% | ||
| Q3 24 | 0.0% | 4.2% | ||
| Q2 24 | 0.0% | 1.9% | ||
| Q1 24 | 0.2% | 1.6% |
现金转化率
APLS
TASK
| Q4 25 | — | 1.00× | ||
| Q3 25 | 0.50× | 1.73× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 1.72× | ||
| Q4 24 | — | 4.59× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 2.38× | ||
| Q1 24 | — | 4.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
TASK
| Digital Customer Experience | $172.7M | 55% |
| Trust And Safety | $82.7M | 26% |
| AI Services | $57.5M | 18% |